ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,479Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 1844

$960K Total Retail Price of All Prescriptions

Rank: 57 out of 1844

692 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 692 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 692 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 15,288 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 799 651 1 1
WARFARIN SODIUM 742 679 2 13
LISINOPRIL 597 443 3 4
POTASSIUM CHLORIDE 530 491 4 16
FUROSEMIDE 493 456 5 7
HYDROCODONE-ACETAMINOPHEN 474 355 S3 6 2
OMEPRAZOLE 392 303 7 5
SIMVASTATIN 365 272 8 3
AMLODIPINE BESYLATE 290 261 9 6
PRAVASTATIN SODIUM 262 246 10 10
CEPHALEXIN 253 211 11 56
METFORMIN HCL 244 166 12 8
METOPROLOL SUCCINATE 236 198 13 14
CITALOPRAM HBR 230 183 14 19
GABAPENTIN 222 171 15 15
CARVEDILOL 214 206 16 22
ATENOLOL 213 199 17 17
DONEPEZIL HCL 205 203 18 26
RANITIDINE HCL 203 156 19 38
METOPROLOL TARTRATE 199 185 20 11
POLYETHYLENE GLYCOL 3350 186 129 21 39
CRESTOR 183 127 22 30
SERTRALINE HCL 178 132 23 21
ATORVASTATIN CALCIUM 177 154 24 12
SODIUM CHLORIDE 176 175 25 170
HYDROCHLOROTHIAZIDE 175 156 26 9
ZOLPIDEM TARTRATE 173 139 27 23
BUMETANIDE 170 155 28 121
AZITHROMYCIN 166 135 29 37
TAMSULOSIN HCL 148 136 30 27
CARBIDOPA-LEVODOPA 140 138 31 86
CYMBALTA 139 128 32 36
DOXAZOSIN MESYLATE 135 106 33 110
PREDNISONE 129 116 34 40
CLOPIDOGREL 129 118 34 34
CIPROFLOXACIN HCL 129 116 34 62
NEXIUM 122 71 37 31
ALLOPURINOL 116 111 38 29
TRAZODONE HCL 115 82 39 43
NAMENDA 111 111 40 33
GLIPIZIDE 104 96 41 70
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 85 42 73
DICLOFENAC SODIUM 101 80 43 122
SPIRONOLACTONE 101 88 43 60
PLAVIX 100 92 45 61
LANTUS 99 99 46 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 84 47 20
GLIPIZIDE ER 92 88 48 79
DIGOXIN 91 91 49 67
LEVOFLOXACIN 90 80 50 78
NOVOLOG 90 88 50 84
ALENDRONATE SODIUM 89 71 52 25
NAPROXEN 85 68 53 87
WATER 83 76 54 177
PANTOPRAZOLE SODIUM 79 70 55 32
DILTIAZEM 24HR CD 79 78 55 132
DILTIAZEM HCL 79 72 55 221
LOVASTATIN 78 72 58 44
TRIAMCINOLONE ACETONIDE 75 68 59 153
FENOFIBRATE 74 46 60 71
METHADONE HCL 74 58 S2 60 133
ROPINIROLE HCL 73 73 62 76
ACETAMINOPHEN-CODEINE 72 71 S3 63 143
LOSARTAN POTASSIUM 68 68 64 24
OXYCODONE-ACETAMINOPHEN 67 46 S2 65 94
CELEBREX 66 56 66 91
METHYLPREDNISOLONE 66 56 66 125
TRAMADOL HCL 66 55 66 18
METOLAZONE 65 51 69 209
METFORMIN HCL ER 64 54 70 46
ESCITALOPRAM OXALATE 63 56 71 52
AVODART 63 63 71 219
IBUPROFEN 63 45 71 89
ISOSORBIDE MONONITRATE ER 60 56 74 59
FLUOXETINE HCL 57 36 75 41
MECLIZINE HCL 56 54 76 142
PAROXETINE HCL 54 38 77 68
ADVAIR DISKUS 54 35 77 51
TRIAMTERENE-HCTZ 52 49 79 48
GLIMEPIRIDE 52 22 79 35
TORSEMIDE 51 49 81 118
IPRATROPIUM-ALBUTEROL 51 47 81 113
FINASTERIDE 50 47 83 137
RISPERIDONE 50 50 83 65
PHENYTOIN SODIUM EXTENDED 50 36 83 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.